Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer.

Ji SonHeather Y LinSiqing FuAmadeo B BiterEcaterina E DumbravaDaniel D KarpAung NaingShubham PantSarina A Piha-PaulJordi RodonVivek SubbiahApostolia M TsimberidouTimothy A YapMichael M FrumovitzAmir A JazaeriPedro T RamirezShannon N WestinYing YuanFunda Meric-BernstamDavid S Hong

Published in: Journal of immunotherapy and precision oncology (2023)

Bone metastasis and absolute lymphocyte count below normal range at phase I study entry portend poor survival in patients with recurrent or metastatic cervical cancer.

Keyphrases

squamous cell carcinoma
small cell lung cancer
peripheral blood
rectal cancer
prostate cancer
randomized controlled trial
bone loss
minimally invasive